GO
Loading...

Drug Retail

More

  • Johnson & Johnson Hits All-Time High     Monday, 1 Apr 2013 | 2:38 PM ET

    Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.

  • Biogen IDEC CEO on Multiple Sclerosis Pill     Thursday, 28 Mar 2013 | 4:35 PM ET

    Biotech has returned 20 percent for investors this year. Biogen IDEC CEO George Scangos, discusses the recent FDA approval of his company's drug, which is its first pill for multiple sclerosis.

  • Pay For Generic Drug Delay     Monday, 25 Mar 2013 | 4:52 PM ET

    The government says big pharma should not be allowed to pay generic drug makers to let them keep their costly branded drugs on the market longer, reports CNBC's Bertha Coombs.

  • Mixed Session For Generic Drugmakers     Monday, 25 Mar 2013 | 1:38 PM ET

    CNBC's Seema Mody reports the latest from the Nasdaq: Drug makers Actavis and AstraZeneca reach an agreement to launch a Crestor generic in 2016.

  • AstraZeneca Settles Patent Dispute     Monday, 25 Mar 2013 | 1:37 PM ET

    AstraZeneca settled a patent dispute with generic drug maker Watson Laboratories over its cholesterol drug Crestor, reports CNBC's Bertha Coombs.

  • Beer and Africa: A Recipe for Profit? Monday, 25 Mar 2013 | 9:56 AM ET

    One sector that is yet to be truly tapped in Africa is the brewing industry, according to research firm Bernstein Research, which believes it is probably the most attractive region for long-term profit growth for global brewers.

  • One Options Trader Bets Walgreen Will See Red Thursday, 14 Mar 2013 | 3:16 PM ET
    Walgreens

    Sometimes, when a stock surges on an analyst upgrade, it's high time to make a bearish bet. That's exactly what one big options trader did on Walgreen.

  • Confidence Back? Several Retailers Top Sales Forecasts Thursday, 7 Mar 2013 | 8:39 AM ET

    After a difficult January, when shoppers first felt the effect of a payroll tax hike that lowered take-home pay by 2 percent, some retailers got a little relief in February from growing employment and a rising stock market.

  • Alex Gorsky

    Containing health care costs, promoting innovation and the treatment of deadly diseases are among the biggest challenges the U.S. faces, Johnson and Johnson CEO Alex Gorsky said on Thursday.

  • Indonesia Central Bank Shuffle Plan Raises Concern Monday, 4 Mar 2013 | 8:31 PM ET
    Pedestrians cross a street in Jakarta's modern business district.

    Moves by Indonesia's President Susilo Bambang Yudhoyono to put his finance minister in charge of the central bank is leading to concerns that he may be seeking someone more malleable to run the state coffers in the run up to next year's elections.

  • You Have to Love a Lucrative 'Drug Deal' Thursday, 28 Feb 2013 | 1:25 PM ET

    The pharmaceutical and biopharmaceutical sectors have been marching steadily higher. TheStreet.com reports on two stocks with potential to appreciate.

  • Mylan CEO on Earnings Beat     Thursday, 28 Feb 2013 | 12:00 AM ET

    Mylan's aquisition of Agila is expected to double its business. Heather Bresch, Myland CEO, offers insight.

  • USPS Takes Armstrong to Court     Friday, 22 Feb 2013 | 1:41 PM ET

    CNBC's Brian Shactman reports the Department of Justice is joining Floyd Landis in a lawsuit accusing Lance Armstrong using performance-enhancing drugs while being sponsored by the U.S. Postal Service. Armstrong says he did not cost the government money. Instead, he says the Postal Service actually benefitted to the tune of more than $100 million from its association with the disgraced cyclist.

  • Global Fight Against Tuberculosis     Friday, 22 Feb 2013 | 1:22 PM ET

    Turberculosis is making a global comeback, including in the United States. Dr. William Schaffner of Vanderbilt University School of Medicine, discusses the concern surrounding the disease.

  • Higher Taxes Put the Brakes on Retail Spending Wednesday, 13 Feb 2013 | 8:33 AM ET

    Retail sales barely rose in January as tax increases and higher gasoline prices restrained spending. Separately, import and export prices rose slightly less than expected in the month.

  • Help Wanted: Washington Weed Czar     Wednesday, 30 Jan 2013 | 1:49 PM ET

    Washington State's liquor control board is seeking a marijuana consultant to help forge ahead regulation for its newly legalized substance. Steve Fox, director of government relations with the Marijuana Policy Project, offers insight.

  • Opko Health CEO on Cytochromas Acquisition     Monday, 28 Jan 2013 | 6:15 PM ET

    Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.

  • Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.

  • Branding & Redemption     Thursday, 17 Jan 2013 | 1:30 PM ET

    The world is gearing up for Lance Armstrong's big interview tonight with Oprah Winfrey. Robbie Vorhaus, founder & CEO of Vorhaus Communications, weighs in.

  • Talking Numbers: Drug War Heats Up     Tuesday, 15 Jan 2013 | 3:30 PM ET

    The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)